De novo molecular drug design benchmarking
Lauren L. Grant, Clarissa S. Sit · RSC Medicinal Chemistry · 2021
Deep neural networks (DNNs) used for de novo drug design have different architectures and hyperparameters that impact the final output of suggested drug candidates. Herein we review benchmarking platforms that assess the utility and validity of DNNs.